Debt-to-equity of BIO-RAD LABORATORIES, INC. from 31 Mar 2011 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
BIO-RAD LABORATORIES, INC. quarterly Debt-to-equity in x history and change rate from 31 Mar 2011 to 31 Dec 2025.
- BIO-RAD LABORATORIES, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 0.43x, a 3.6% increase year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
BIO-RAD LABORATORIES, INC. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.43x | +0.02x | +3.6% | 31 Dec 2025 |
| Q3 2025 | 0.43x | +0.02x | +5.2% | 30 Sep 2025 |
| Q2 2025 | 0.42x | +0.02x | +3.8% | 30 Jun 2025 |
| Q1 2025 | 0.42x | +0.02x | +4% | 31 Mar 2025 |
| Q4 2024 | 0.41x | +0.01x | +1.2% | 31 Dec 2024 |
| Q3 2024 | 0.41x | +0x | +0.37% | 30 Sep 2024 |
| Q2 2024 | 0.41x | -0x | -0.42% | 30 Jun 2024 |
| Q1 2024 | 0.41x | -0x | -1% | 31 Mar 2024 |
| Q4 2023 | 0.41x | -0.01x | -1.3% | 31 Dec 2023 |
| Q3 2023 | 0.41x | +0.03x | +7.7% | 30 Sep 2023 |
| Q2 2023 | 0.41x | +0.06x | +19% | 30 Jun 2023 |
| Q1 2023 | 0.41x | +0.09x | +27% | 31 Mar 2023 |
| Q4 2022 | 0.41x | +0.11x | +36% | 31 Dec 2022 |
| Q3 2022 | 0.38x | +0.07x | +24% | 30 Sep 2022 |
| Q2 2022 | 0.35x | +0.03x | +7.9% | 30 Jun 2022 |
| Q1 2022 | 0.32x | -0.01x | -3.9% | 31 Mar 2022 |
| Q4 2021 | 0.3x | -0.05x | -14% | 31 Dec 2021 |
| Q3 2021 | 0.31x | -0.07x | -18% | 30 Sep 2021 |
| Q2 2021 | 0.32x | -0.06x | -17% | 30 Jun 2021 |
| Q1 2021 | 0.34x | -0.05x | -14% | 31 Mar 2021 |
| Q4 2020 | 0.35x | -0.05x | -11% | 31 Dec 2020 |
| Q3 2020 | 0.38x | -0.02x | -6.2% | 30 Sep 2020 |
| Q2 2020 | 0.38x | -0.01x | -2.1% | 30 Jun 2020 |
| Q1 2020 | 0.39x | +0x | +0.54% | 31 Mar 2020 |
| Q4 2019 | 0.4x | +0.02x | +4.4% | 31 Dec 2019 |
| Q3 2019 | 0.4x | +0.01x | +2.2% | 30 Sep 2019 |
| Q2 2019 | 0.39x | -0.02x | -4.9% | 30 Jun 2019 |
| Q1 2019 | 0.39x | -0.05x | -12% | 31 Mar 2019 |
| Q4 2018 | 0.38x | -0.08x | -18% | 31 Dec 2018 |
| Q3 2018 | 0.39x | -0.08x | -17% | 30 Sep 2018 |
| Q2 2018 | 0.41x | -0.07x | -14% | 30 Jun 2018 |
| Q1 2018 | 0.44x | -0.04x | -8.6% | 31 Mar 2018 |
| Q4 2017 | 0.47x | -0.02x | -3.9% | 31 Dec 2017 |
| Q3 2017 | 0.47x | -0.01x | -2.1% | 30 Sep 2017 |
| Q2 2017 | 0.48x | -0.01x | -2.2% | 30 Jun 2017 |
| Q1 2017 | 0.48x | -0.01x | -2.4% | 31 Mar 2017 |
| Q4 2016 | 0.48x | -0.02x | -3.4% | 31 Dec 2016 |
| Q3 2016 | 0.48x | -0.03x | -5.3% | 30 Sep 2016 |
| Q2 2016 | 0.49x | -0.03x | -6.4% | 30 Jun 2016 |
| Q1 2016 | 0.49x | -0.04x | -8% | 31 Mar 2016 |
| Q4 2015 | 0.5x | -0.04x | -7.5% | 31 Dec 2015 |
| Q3 2015 | 0.51x | -0.04x | -6.6% | 30 Sep 2015 |
| Q2 2015 | 0.52x | -0.02x | -4% | 30 Jun 2015 |
| Q1 2015 | 0.53x | -0.04x | -7.5% | 31 Mar 2015 |
| Q4 2014 | 0.54x | -0.08x | -12% | 31 Dec 2014 |
| Q3 2014 | 0.55x | -0.11x | -17% | 30 Sep 2014 |
| Q2 2014 | 0.54x | -0.16x | -22% | 30 Jun 2014 |
| Q1 2014 | 0.58x | -0.13x | -18% | 31 Mar 2014 |
| Q4 2013 | 0.62x | -0.1x | -14% | 31 Dec 2013 |
| Q3 2013 | 0.66x | -0.07x | -9.9% | 30 Sep 2013 |
| Q2 2013 | 0.7x | -0.04x | -5.8% | 30 Jun 2013 |
| Q1 2013 | 0.71x | -0.05x | -6.5% | 31 Mar 2013 |
| Q4 2012 | 0.71x | -0.06x | -7.7% | 31 Dec 2012 |
| Q3 2012 | 0.73x | -0.09x | -11% | 30 Sep 2012 |
| Q2 2012 | 0.74x | -0.11x | -13% | 30 Jun 2012 |
| Q1 2012 | 0.76x | -0.15x | -16% | 31 Mar 2012 |
| Q4 2011 | 0.77x | 31 Dec 2011 | ||
| Q3 2011 | 0.82x | 30 Sep 2011 | ||
| Q2 2011 | 0.86x | 30 Jun 2011 | ||
| Q1 2011 | 0.9x | 31 Mar 2011 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.